Lyell Immunopharma
Developing next-generation T-cell therapies for patients with solid tumors.
Company facts
- Founded
- 2018
- Employees
- 300
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: LYEL
Open positions
Associate Director, Medical Affairs Operations
Oversee Medical Affairs operations for a biotech firm developing next-gen CAR T-cell therapies, building systems, budgets, and AI-enabled workflows to support clinical launches and compliance.
Associate Director, FP&A
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies.…
Director, Medical Writing
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies.…
Associate Director, Clinical Development Program Management
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies.…
Director or Senior Director, Investor Relations and Corporate Communications
Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies.…